Knowledge, attitude and practice of hospital pharmacists towards pharmacovigilance and adverse drug reaction reporting in Najran, Saudi Arabia

Abdel-Latif, 2015, Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia, Saudi Pharm. J., 23, 154, 10.1016/j.jsps.2014.07.005 Abu Farha, 2018, Effect of educational intervention on healthcare providers knowledge and perception towards pharmacovigilance: A tertiary teaching hospital experience, Saudi Pharm. J., 26, 611, 10.1016/j.jsps.2018.03.002 Ahmad, 2013, An evaluation of knowledge, attitude and practice of Indian pharmacists towards adverse drug reaction reporting: A pilot study, Perspect. Clin. Res., 4, 204, 10.4103/2229-3485.120168 Alharbi, 2016, Attitude, knowledge and experience of hospital pharmacists with pharmacovigilance in a region in Saudi Arabia: a cross-sectional study, Trop. J. Pharm. Res., 15, 1773, 10.4314/tjpr.v15i8.25 Al-Hazmi, 2013, Attitude and awareness of adverse drug reaction reporting by health professionals in seven hospitals in the Holy City of Makkah, kingdom of Saudi Arabia, J. Clin. Trials, 03 Ali, 2018, Knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process among Health Care Providers in Dammam, Saudi Arabia. Curr. Drug Saf., 13, 21, 10.2174/1574886313666171218123802 Almandil, 2016, Healthcare professionals’ awareness and knowledge of adverse drug reactions and pharmacovigilance, Saudi Med. J., 37, 1359, 10.15537/smj.2016.12.17059 Alsaleh, 2017, Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in Kuwait, Saudi Pharm. J., 25, 830, 10.1016/j.jsps.2016.12.004 AlShammari, 2018, Knowledge, attitudes & practices of healthcare professionals in hospitals towards the reporting of adverse drug reactions in Saudi Arabia: A multi-centre cross sectional study, Saudi Pharm. J., 26, 925, 10.1016/j.jsps.2018.04.012 Alshammari, 2017, Pharmacovigilance systmen in Saudi Arabia, Saudi Pharm J, 25, 299, 10.1016/j.jsps.2016.09.008 Alshayban, 2020, Pharmacovigilance perception and knowledge among pharmacists and interns in Saudi Arabia, Risk Manag. Healthc. Policy, 13, 55, 10.2147/RMHP.S241265 Amin, 2016, Cross-sectional study exploring barriers to adverse drug reactions reporting in community pharmacy settings in Dhaka, Bangladesh. BMJ Open, 6, e010912, 10.1136/bmjopen-2015-010912 Bahnassi, 2018, Syrian pharmacovigilance system: a survey of pharmacists’ knowledge, attitudes and practices, East. Mediterr. Health J., 24, 569, 10.26719/2018.24.6.569 Bouvy, 2015, Epidemiology of adverse drug reactions in Europe: a review of recent observational studies, Drug Saf., 38, 437, 10.1007/s40264-015-0281-0 Campbell, 2014, A review of pharmacovigilance, West Indian Med. J., 63, 771 Faqihi, 2019, Pharmacist’s knowledge, attitude, and practice towards pharmacovigilance and adverse drug reactions reporting process: a cross-sectional survey, Int. J. Med. Dev. Ctries., 409 Ferner, 2018, Adverse drug reactions, BMJ, 363 Gildeeva, 2017, Pharmacovigilance in Russian Federation: Construction, Development and Reforms of PV System, Pharm RegulAff, 6, 1000187 Güner, 2019, Healthcare professionals’ pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates, J. Drug Assess., 8, 13, 10.1080/21556660.2019.1566137 Gupta, 2015, A questionnaire study on the knowledge, attitude, and the practice of pharmacovigilance among the healthcare professionals in a teaching hospital in South India, Perspect. Clin. Res., 6, 45, 10.4103/2229-3485.148816 Hadi, 2017, Pharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reporting, Integr. Pharm. Res. Pract., 6, 91, 10.2147/IPRP.S105881 Hanafi, 2014, An educational intervention to improve nurses’ knowledge, attitude, and practice toward reporting of adverse drug reactions, Iran. J. Nurs. Midwifery Res., 19, 101 Herdeiro, 2012, Workshop- and telephone-based interventions to improve adverse drug reaction reporting: a cluster-randomized trial in Portugal: a cluster-randomized trial in Portugal, Drug Saf., 35, 655, 10.1007/BF03261962 Hussain, 2021, Exploring healthcare professionals’ knowledge, attitude, and practices towards pharmacovigilance: a cross-sectional survey, J. Pharm. Policy Pract., 14, 5, 10.1186/s40545-020-00287-3 Ibrahim, 2021, Pharmacovigilance education to healthcare professionals: Will it affect their performance in reporting adverse drug reactions?, Int. J. Clin. Pract., 75, 10.1111/ijcp.14731 Jose, 2014, A cross sectional pilot study on assessing the knowledge, attitude and behavior of community pharmacists to adverse drug reaction related aspects in the Sultanate of Oman, Saudi Pharm. J., 22, 163, 10.1016/j.jsps.2013.07.006 Khan, 2013, Adverse drug reactions in hospitalized pediatric patients of Saudi Arabian University Hospital and impact of pharmacovigilance in reporting ADR, Saudi Pharm. J., 21, 261, 10.1016/j.jsps.2012.09.004 Khan, 2012, Impact of pharmacovigilance on adverse drug reactions reporting in hospitalized internal medicine patients at Saudi Arabian teaching hospital, Saudi Med. J., 33, 863 Lemay, 2018, Reporting of adverse drug reactions in primary care settings in Kuwait: A comparative study of physicians and pharmacists, Med. Princ. Pract., 27, 30, 10.1159/000487236 Li, 2018, Community pharmacists’ knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey, Int. J. Clin. Pharm., 40, 878, 10.1007/s11096-018-0700-2 Lopez-Gonzalez, 2009, Determinants of underreporting of adverse drug reactions: a systematic review, Drug Saf, 32, 19, 10.2165/00002018-200932010-00002 Nisa, 2018, Assessment of knowledge, attitude and practice of adverse drug reaction reporting among healthcare professionals in secondary and tertiary hospitals in the capital of Pakistan, Saudi Pharm. J., 26, 453, 10.1016/j.jsps.2018.02.014 Palaian, 2011, Health professionals’ knowledge, attitude and practices towards pharmacovigilance in Nepal, Pharm. Pract. (Granada), 9, 228, 10.4321/S1886-36552011000400008 Pirmohamed, 2004, Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients, BMJ, 329, 15, 10.1136/bmj.329.7456.15 Said, 2017, Adverse drug reaction reporting practices among United Arab Emirates pharmacists and prescribers, Hosp. Pharm., 52, 361, 10.1177/0018578717715364 Shamim, 2016, Adverse drug reactions (ADRS) reporting: awareness and reasons of under-reporting among health care professionals, a challenge for pharmacists, Springerplus, 5, 1778, 10.1186/s40064-016-3337-4 Sibbald, 2004, Rofecoxib (Vioxx) voluntarily withdrawn from market, CMAJ, 171, 1027, 10.1503/cmaj.1041606 Stausberg, 2014, International prevalence of adverse drug events in hospitals: an analysis of routine data from England, Germany, and the USA, BMC Health Serv. Res., 14, 125, 10.1186/1472-6963-14-125 Suyagh, 2015, Pharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process, Saudi Pharm. J., 23, 147, 10.1016/j.jsps.2014.07.001 Tadvi, 2018, Knowledge, Attitude and Practice of Pharmacovigilance in Healthcare Professionals and Medical Students in Majmaah, Saudi Arabia Care Centre, Int. J. Med. Res. Health Sci., 7, 101 World Health Organization, 2002a. The importance of pharmacovigilance: Produced by WHO quality assurance and safety team. World Health Organization, Genève, Switzerland. World Health Organization. Quality Assurance, Safety of Medicines Team, 2002b. Safety of medicines : a guide to detecting and reporting adverse drug reactions : why health professionals need to take action. World Health Organization.